ES2141380T3 - Metodo para la fabricacion de un comprimido recubierto, con nucleo puntiagudo. - Google Patents

Metodo para la fabricacion de un comprimido recubierto, con nucleo puntiagudo.

Info

Publication number
ES2141380T3
ES2141380T3 ES95931985T ES95931985T ES2141380T3 ES 2141380 T3 ES2141380 T3 ES 2141380T3 ES 95931985 T ES95931985 T ES 95931985T ES 95931985 T ES95931985 T ES 95931985T ES 2141380 T3 ES2141380 T3 ES 2141380T3
Authority
ES
Spain
Prior art keywords
manufacture
coated tablet
dry
pointed core
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95931985T
Other languages
English (en)
Inventor
Karsten Cremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2141380T3 publication Critical patent/ES2141380T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047—Detergents in the form of bars or tablets
    • C11D17/0065—Solid detergents containing builders
    • C11D17/0073—Tablets
    • C11D17/0078—Multilayered tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047—Detergents in the form of bars or tablets
    • C11D17/0056—Lavatory cleansing blocks
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047—Detergents in the form of bars or tablets
    • C11D17/0065—Solid detergents containing builders
    • C11D17/0073—Tablets
    • C11D17/0082—Coated tablets

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN TABLETA LAMINADA PARA LA LIBERACION CONTROLADA DE PRINCIPIO ACTIVO CON NUCLEO (1) EROSIONABLE Y CONTENIENDO AL MENOS UN PRINCIPIO ACTIVO, Y UNA CUBIERTA MUY RESISTENTE A LA EROSION Y COMPUESTA DE UNA CAPA DE RECUBRIMIENTO; LA TABLETA SE CARACTERIZA PORQUE LA CAPA DE RECUBRIMIENTO (5) TIENE AL MENOS UNA ABERTURA (6) Y EL NUCLEO (1) LLEGA POR UNO DE SUS EXTREMOS A LA ABERTURA (6).
ES95931985T 1994-09-06 1995-09-04 Metodo para la fabricacion de un comprimido recubierto, con nucleo puntiagudo. Expired - Lifetime ES2141380T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4431653A DE4431653C2 (de) 1994-09-06 1994-09-06 Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2141380T3 true ES2141380T3 (es) 2000-03-16

Family

ID=6527497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95931985T Expired - Lifetime ES2141380T3 (es) 1994-09-06 1995-09-04 Metodo para la fabricacion de un comprimido recubierto, con nucleo puntiagudo.

Country Status (10)

Country Link
US (1) US6264985B1 (es)
EP (1) EP0779807B1 (es)
JP (1) JPH10505264A (es)
AT (1) ATE186211T1 (es)
CA (1) CA2199249C (es)
DE (2) DE4431653C2 (es)
DK (1) DK0779807T3 (es)
ES (1) ES2141380T3 (es)
GR (1) GR3032524T3 (es)
WO (1) WO1996007401A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338819A1 (en) * 1998-07-29 2000-02-10 Guido Waeschenbach Composition for use in a water reservoir
CA2338710C (en) * 1998-07-29 2009-10-27 Guido Waeschenbach A tablet comprising a basic composition and particle comprising core and envelope
JP2000139322A (ja) * 1998-11-11 2000-05-23 Maruyama Mfg Co Ltd 粉粒剤散布方法及びこの粉粒剤散布方法に使用される粉粒剤
DE19856214C1 (de) * 1998-12-05 2000-03-09 Henkel Kgaa Punkttablette
GB9901688D0 (en) 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
DE19963570A1 (de) * 1999-12-29 2001-07-26 Reckitt Benckiser Nv Zusammensetzung zur Verwendung in einer Geschirrspülmaschine mit einer Basiszusammensetzung in Form einer Tablette
DE19963569B4 (de) * 1999-12-29 2006-11-16 Reckitt Benckiser N.V. Zusammensetzung zur Verwendung in einer Geschirrspülmaschine
US6569152B2 (en) * 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
DE10127897B4 (de) 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
CA2461354C (en) * 2001-09-28 2010-04-27 Mcneil-Ppc, Inc. Fondant-based pharmaceutical composition
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EA006053B1 (ru) * 2001-12-24 2005-08-25 Тева Фармасьютикал Индастриес Лтд. Твёрдая лекарственная форма, способ её изготовления и устройство
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
AU2003217909C1 (en) * 2002-03-04 2009-06-11 Teva Pharmaceutical Industries Ltd. Controlled release dosage forms
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
MXPA05003283A (es) * 2002-09-28 2005-11-23 Johnson & Johnson Composicion de polimero y formas de dosis que comprenden la misma.
EP1545472B1 (en) 2002-09-28 2010-12-08 McNeil-PPC, Inc. Modified release dosage forms with two cores and an opening
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20060002986A1 (en) * 2004-06-09 2006-01-05 Smithkline Beecham Corporation Pharmaceutical product
CA2575006A1 (en) * 2004-07-26 2006-02-02 E. Itzhak Lerner Dosage forms with an enterically coated core tablet
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
CA2588245A1 (en) * 2004-09-13 2006-03-23 L. Perrigo Company Quick dissolve medicament and method of manufacturing
DE102004051620A1 (de) * 2004-10-22 2006-04-27 Henkel Kgaa Wasch- oder Reinigungsmittel
WO2009023006A2 (en) * 2006-05-08 2009-02-19 Mcneil-Ppc, Inc. Modified release dosage form
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
EP2651399A2 (en) 2010-12-13 2013-10-23 Purdue Pharma LP Controlled release dosage forms
DE102011051653A1 (de) 2011-07-07 2013-01-10 Lts Lohmann Therapie-Systeme Ag Quellfähige Manteltablette
CN103948557A (zh) 2014-04-08 2014-07-30 闻晓光 一种新型控释片
DE102014107026B4 (de) * 2014-05-19 2017-07-13 Romaco Kilian Gmbh Vorrichtung zum Herstellen von Kerntabletten sowie Mantelkerntabletten (Doppelkern- oder Mehrfachkerntablette)
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
US20190336396A1 (en) * 2017-01-17 2019-11-07 Freund Corporation Tablet production device, tablet production method, and tablet
US20200338878A1 (en) * 2017-05-31 2020-10-29 Hanbat National University Industry-Academic Cooperation Foundation Method for manufacturing lightweight high-strength material using middle fragment of shell
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US994742A (en) * 1910-04-08 1911-06-13 Marshal J Gregory Fence-post foundation.
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
US3924622A (en) 1973-10-11 1975-12-09 Mead Johnson & Co Zero-order release method
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4692336A (en) * 1984-03-19 1987-09-08 Alza Corporation Self controlled release device for administering beneficial agent to recipient
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
GB8820353D0 (en) 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
EP0664118B1 (en) * 1991-10-04 1999-08-25 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release tablet
ATE133331T1 (de) * 1991-11-13 1996-02-15 Glaxo Canada Vorrichtung zur kontrollierten wirkstoffreigabe
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung

Also Published As

Publication number Publication date
DK0779807T3 (da) 2000-05-08
EP0779807A1 (de) 1997-06-25
DE4431653A1 (de) 1996-03-07
WO1996007401A1 (de) 1996-03-14
GR3032524T3 (en) 2000-05-31
US6264985B1 (en) 2001-07-24
CA2199249C (en) 2005-12-27
JPH10505264A (ja) 1998-05-26
ATE186211T1 (de) 1999-11-15
EP0779807B1 (de) 1999-11-03
CA2199249A1 (en) 1996-03-14
DE59507193D1 (de) 1999-12-09
DE4431653C2 (de) 2000-01-20

Similar Documents

Publication Publication Date Title
ES2141380T3 (es) Metodo para la fabricacion de un comprimido recubierto, con nucleo puntiagudo.
ZA200509477B (en) Delayed release tablet with defined core geometry
CY2396B1 (en) Pharmaceutical composition of fenofibrate with high biological availability and method for preparingsame.
ES2137888B1 (es) Agente antifungico, compuesto para el mismo procedimiento para su produccion y metodo para su utilizacion.
MY112915A (en) Multiple unit tableted dosage form 1
MX9600858A (es) Nuevas perlas o globulos para liberacion controlada y una preparacion farmaceutica que contiene las mismas.
AR240302A1 (es) Una composicion de peroxido de hidrogeno acuosa estabilizada y procedimiento para su preparacion.
AU2369695A (en) Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same
AR024492A1 (es) Formas de dosificacion farmaceutica para liberacion controlada que comprenden al menos un impulso ciclico
EP0196334A4 (en) METHOD FOR DESTROYING CELLS AND CELL KILLING AGENTS.
UA42795C2 (uk) Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання
BR9807368A (pt) Comprimidos de oxacarvazepina revestidos com pelìcula
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
WO1995022974A3 (en) Film coated tablet of paracetamol and domperidone
HU9600956D0 (en) Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them
ES8800048A1 (es) Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada.
ATE249208T1 (de) Geschmacksmaskierte kautablette mit sofortiger wirkstofffreisetzung sowie herstellungsverfahren
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну
ES2124065T5 (es) Procedimiento continuo para la fabricacion de alcoxido sodico c4-c8.
HUP0104950A3 (en) Composition containing glycerol trinitrate, method for producing said composition and use of the same
AU6538898A (en) Method and apparatus for altering the osmotic pressure of cryopreserved white stem cells
ES2155131T3 (es) Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos.
DE69023241D1 (de) Ionophore enthaltende abgabevorrichtung.
DE3261448D1 (en) Derivative of acetylsalicylic acid having an analgetic, antipyretic, antiphlogistic and bronchosecretolytic activity
AR014534A1 (es) Un metodo para producir una composicion eliminadora de oxigeno y un envase que comprende dicha composicion".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 779807

Country of ref document: ES